FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Physostigmine Salicylate Injection
Status: Currently in Shortage
»Date first posted: 02/21/2019
»Therapeutic Categories: Neurology

Akorn Pharmaceuticals (Reverified 05/19/2021)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Physostigmine Salicylate Injection, USP 1mg/mL (10amps/box, 2mL each) (NDC 17478-510-02) On backorder. Expected release - Q3 2021 Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English